Advanced Search
Contact | Corporate | Help
  • Home
  • Software Solutions
    • Login Now
    • Supplier Management(SRM) >>
      • Overview
      • CMO/CRO Projects
      • Construction Projects
      • Equipment Purchases
      • HR Services
      • Sales and Marketing
      • Security
      • Login Now
    • Client Portal >>
      • Overview
      • Security
      • Login Now
    • Software-as-a-Service
    • RFP Calculator
    • Product Tour
    • FAQs
  • Resources
    • Clinical Trials
    • Company Directories >>
      • Biotech & Pharma
      • CMOs & CROs
      • Engineering & Architecture
      • HR & Recruiters
      • Law Firms
      • Real Estate
    • Events
    • Jobs
    • News >>
      • Current News
      • May 23, 2012
      • May 22, 2012
      • May 21, 2012
      • May 17, 2012
      • May 16, 2012
      • May 15, 2012
      • May 14, 2012
      • May 11, 2012
      • May 10, 2012
      • May 09, 2012
      • May 08, 2012
      • May 07, 2012
      • May 06, 2012
      • Apr 25, 2012
      • Apr 24, 2012
    • Industry Organizations
    • Regulatory Resources >>
      • Consultants
      • FDA Documents
      • ICH Documents
      • Worldwide Agencies
    • Useful Websites
  • Corporate
    • About Us
    • Careers
    • Corporate News
    • Contact
    • Partners
    • SourceSolution IQPC Workshop

  • Company Directories >>
    • CMOs/CROs
    • Biotech/Pharma
    • Professional Services
    • Regulatory Consultants
  • Events
  • News >>
    • Current News
    • Daily News Email Sign-up
  • Industry Organizations
  • Jobs
  • Regulatory Resources >>
    • FDA Documents
    • ICH Documents
    • Regulatory Agencies
    • Documents
    • Useful Websites
  • Clinical Trials

Angion Biomedica Corporation Bookmark and Share

  • Overview
  • LinkedIn®
  • Visit
  • Jobs
  • News
  • Pipleline
  • Management
ArticleDateSource
Angion Biomedica Corp. Enters Multi-Institutional Alliance to Advance Novel and Promising Therapies for Ischemic Stroke May 09, 2011BioSpace - Breaking News
Angion Biomedica Enters Multi-Institutional Alliance to Advance Novel and Promising Therapies for Ischemic StrokeMay 09, 2011Pharma News - Business Wire
Angion Biomedica Corp. Receives Fast Track and Orphan Drug Product Designations from FDA for its Lead Therapeutic, BB3 July 06, 2010BioSpace
Angion Biomedica Receives Fast Track and Orphan Drug Product Designations from FDA for its Lead Therapeutic, BB3July 06, 2010FDA News - Business Wire
Angion Biomedica Corp.-Company Report - New Report PublishedMarch 22, 2010Biotechnology - Moreover



View all the latest news

SourceSolution © 2008-2012